cutaneous leishmaniasis. Cutaneous leishmaniasis
Conditions
Interventions
Intervention 1: Intervention group: Topical amphotericin ointment (0.4% Sina ampholish gel, every 12 hours) along with intralesional injection of glucantime (intralesional injection of glucantime 1.5m
Sponsors
Esfahan University of Medical Sciences
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Cutaneous leishmaniasis infection confirmed by PCR Written informed consent to participate in the study after being explained about the study procedures and possible complications Not having a history of drug reaction to the studied treatments
Exclusion criteria
Exclusion criteria: History of immunodeficiency Pregnancy and breastfeeding Sign or symptoms of malnutrition History of cardiac, renal or hepatic diseases Severe allergic reaction or adverse effects due to Glucantim or Amphotricine that interfere with the treatment Violating study protocol Refusing treatment during follow up or lost contact
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The size of the lesion. Timepoint: Weekly follow-up up to a maximum of 12 weeks. Method of measurement: ruler. | — |
Secondary
| Measure | Time frame |
|---|---|
| The size of scar. Timepoint: Weekly follow-up up to a maximum of 12 weeks. Method of measurement: Ruler. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactNazila Poostiyan
Esfarayen University of Medical Sciences
Outcome results
None listed